The Eating Assessment Tool (EAT-10)

The EAT-10 is an Eating Assessment Tool that consists of 10 questions and is easy to administer and score. It is validated in ALS and has “excellent accuracy” in identifying patients who aspirate.¹ Each of the 10 items assesses if the patient has no problems swallowing to severe difficulties swallowing.

An EAT-10 score of 3 or higher suggests that a person may have difficulty swallowing and should discuss their results with their physician. Results from the EAT-10 is not equivalent to a clinical swallowing evaluation or instrumental assessment – only your physician can determine this.

Click here and print out the EAT-10. Bring the completed form with you to your next doctor’s appointment to discuss your results.

Reference

1. Plowman EK. Neurogastroenterol Motil. (2016); 28(1):85.

Expand

Indication

TIGLUTIK (riluzole) is a prescription medicine for the treatment of amyotrophic lateral sclerosis (ALS).

Important Safety Information

You should not take TIGLUTIK if you are allergic to any of its ingredients.
TIGLUTIK can cause liver injury, including death. Your doctor should do blood tests to check your liver function before and during your treatment and may stop treatment with TIGLUTIK if liver function is not normal. Contact your doctor immediately if you have unexplained nausea, vomiting, abdominal pain, fatigue, anorexia, or jaundice and/or dark urine.
Call your doctor immediately if you have a fever, cough, or difficulty in breathing while taking TIGLUTIK.
If you miss or skip a dose of TIGLUTIK, do not take any extra dose to make up for those you missed, but take your prescribed dose at the next regularly scheduled time.
The most common side effects of TIGLUTIK that occurred during medical studies were numbness/tingling around the mouth, weakness, nausea, decreased lung function, high blood pressure, and abdominal pain. If any side effects become troublesome, contact your doctor.
Be sure to tell your doctor and pharmacist about all other health conditions you have and all medicines you are taking, including nonprescription products and vitamins. If you have questions, please talk to your doctor.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-332-1088.

Please click here for the Full Prescribing Information.

Intended for U.S. Residents Only

3 Paoli Plaza, Suite C
Paoli, PA 19301 United States
Medical/Product Inquiries: 844-763-1198
EDW Pharma US Headquarters: 610-937-6172
medicalinquiry@edwpharma.com
www.edwpharma.com